MedPath
NMPA Approval

Lanadelumab Injection

国药准字SJ20200025

December 2, 2020

Drug Information

拉那利尤单抗注射液

达泽优

注射剂

300mg/2ml(150mg/ml)

生物制品

December 2, 2020

December 1, 2025

Company Information

Applicant Company

95 Hayden Avenue, Lexington, MA 02421, United States of America

Manufacturing Company

1300 South Patterson Drive, Bloomington, IN 47403, United States of America

© Copyright 2025. All Rights Reserved by MedPath
拉那利尤单抗注射液 - NMPA 批准文号 | MedPath